The company also said it is working with the MD Anderson Cancer Center to develop NGS-based assays for lung cancer.
The company will begin offering Thermo Fisher's Oncomine Focus Assay and the Oncomine Comprehensive Assay.
Salk Institute researchers have constructed a human methylome map to uncover tissue-specific variations as well as non-canonical methylation.
Sysmex's cell-free tumor DNA analysis technology will be used in oncology clinical trials supported by Covance Drug Development, a LabCorp subsidiary.
Researchers explored the predictive value of using mismatch repair deficiency and PD-L1 expression to assess which cancer patients are likely to respond to anti-PD-1 treatments.
In PLOS this week: Plasmodium knowlesi population genetics, oral microbiome of infants and children, and more.
The New York Times editorial board weighs in on scientific research misconduct.
The European Commission says it won't take funds from the European Research Council's budget for its new European Fund for Strategic Investment.
The case of the 'devious defecator' examines the protections of the Genetic Information Nondiscrimination Act.
This webinar will demonstrate how automated liquid handling workstations can reduce bottlenecks in library preparation for next-generation sequencing, enabling scientific advances in genomics research that were not possible five years ago.